Using violet light to reduce myopia in children
Violet Light for Treatment of Myopia
This study is testing if using violet light lamps can help slow down the worsening of nearsightedness in children aged 5 to 12 compared to regular white light.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 72 (estimated) |
| Ages | 5 Years to 12 Years |
| Sex | All |
| Sponsor | Children's Hospital Medical Center, Cincinnati Academic / other |
| Locations | 1 site (Cincinnati, Ohio) |
| Trial ID | NCT06110520 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of violet light-emitting lamps on the progression of myopia in children aged 5 to 12. Participants will be exposed to violet light during dawn and dusk, while a control group will use regular white light lamps. The goal is to determine if violet light can effectively suppress myopia progression compared to standard lighting. The study will measure changes in refractive error over time to assess the efficacy of this intervention.
Who should consider this trial
Good fit: Ideal candidates are children aged 5 to 12 diagnosed with myopia and specific refractive error criteria.
Not a fit: Patients with a history of certain eye conditions or previous myopia treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a non-invasive method to slow down the progression of myopia in children.
How similar studies have performed: While the use of light therapy for myopia is a novel approach, similar studies exploring light exposure effects on eye health have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children must be between 5 to \<13 years old. * Diagnosis of Myopia (ICD-10-CM Diagnosis Code H52.13) with refractive error: 1. Myopia -1.00D to -6.00D spherical equivalent (SE) in both eyes 2. Astigmatism \<=1.50D in both eyes 3. Anisometropia \<=1.00D SE • Relocation outside of the CCHMC area within the next 12 months is not anticipated. Exclusion Criteria: Current or previous myopia treatment with atropine, pirenzepine, or other antimuscarinic agents * Current or previous use of bifocals, progressive addition lenses, or multi-focal contact lenses * Current or previous use of orthoK, rigid gas permeable, or other contact lenses being used to reduce myopia progression * Current or prior history of manifest strabismus, amblyopia, or nystagmus * Abnormality of cornea, lens, central retina, iris, or ciliary body * Prior eyelid, strabismus, intraocular, or refractive surgery * Down syndrome or cerebral palsy
Where this trial is running
Cincinnati, Ohio
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States (Recruiting)
Study contacts
- Study coordinator: Jillian Bulman, MPH
- Email: jillian.bulman@cchmc.org
- Phone: 9374034996
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.